FutureTech II Acquisition Corp.
FTIIDelisted Jul 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001889450
FutureTech II Acquisition Corp. was delisted on Jul 11, 2025; its insiders filed their last Form 4 on Feb 6, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in FutureTech II Acquisition Corp. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
FTII is no longer listed, so this page shows Q2 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 0
- 0 vs. Q1 2025
- Shares held
- 0
- 0 vs. Q1 2025
- Total value
- $0
- $0 vs. Q1 2025
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting FTII on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 7 | $14.5M |
| Q3 2024 | 12 | $17.5M |
| Q2 2024 | 14 | $18.4M |
| Q1 2024 | 10 | $19.8M |
| Q4 2023 | 22 | $59.1M |
| Q3 2023 | 21 | $59.1M |
| Q2 2023 | 41 | $118.1M |
| Q1 2023 | 42 | $116.6M |
| Q4 2022 | 34 | $103.7M |
| Q3 2022 | 33 | $96.6M |
| Q2 2022 | 31 | $83.4M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding FutureTech II Acquisition Corp.; share changes are against Q1 2025.
No institution reported holding FTII in Q2 2025.